Solventum Corporation Overview
Pro stress-test →Solventum is an American healthcare company spun off from 3M on April 1, 2024. The company develops, manufactures, and commercializes healthcare solutions to address critical customer and patient needs globally. With $8.4B in revenue and a diverse portfolio spanning wound care, dental solutions, and health information systems, Solventum operates as a pure-play healthcare innovator.
Strategic Profile
Pro stress-test →Solventum operates in three segments: Medsurg, Dental Solutions, and Health Information Systems, with Medsurg representing approximately 64% of revenue. The company has divested its purification and filtration segment, enabling sharper strategic focus. The recent acquisition of Acera Surgical in December 2025 expands capabilities in engineered materials for regenerative wound care, demonstrating disciplined portfolio expansion.
Competitive Landscape
Pro stress-test →Key competitors include Baxter International, ResMed, Hologic, DENTSPLY SIRONA, and Align Technology. Solventum competes across medical devices, dental technology, and health IT—fragmented markets where scale, innovation, and regulatory relationships drive competition. Post-spin independence enhances agility versus legacy conglomerates.
Industry Context
Solventum Corporation operates in Healthcare Devices & Services.
Key facts
Founded: 2024 · Headquarters: Maplewood, Minnesota · Employees: 20000 · Revenue: $8.4B · Market cap: $14.0B